The Presage® ST2 Assay is to be offered by Quest Diagnostics and LabCorp following agreements with the company who market the test, Critical Diagnostics.
Identification of potential biomarkers for difficult-to-diagnose Kawasaki disease.
Robert Gerszten receives an Agilent Thought Leader Award from Agilent Technologies Inc.
Genisphere and Lankenau Institute for Medical Research collaborate in the development of targeted nanotherapeutics.
Advion has recently revealed that its expression compact mass spectrometer is compatible with Agilent Technologies’ HPLC and UHPLC systems.
A Japanese research group recently published data on a new method for determining D-serine, a protein which could be used as a biomarker for measuring effects new drugs have on the central nervous system, in a mouse brain.
System targets personalized medicine for biomarker discovery and predicting drug efficacy.
World’s largest clinical trial in pre- and early diabetes utilizes Myriad RBM’s biomarker technology.
PharmaDiagnostics’ assay product range and development strategy is set to benefit with the acquisition of a former pharma department head to the executive team.